NYSE · CIK 0000051253
IFF INTERNATIONAL FLAVORS & FRAGRANCES INC
Insider trading from SEC Form 4. Last filing Mar 6, 2025. Close $84.55 on Oct 9, 2026, +45% from the 52-week low and -4% from the high.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
15
with a Form 4 at this company
Price and insider trades, last year
IFFOct 9, 2026 · close 84.55
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at INTERNATIONAL FLAVORS & FRAGRANCES INC, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 49Moderate | buy 2 | Kevin O'Byrne director | $523k | 6,500 | - | - | |
| 68Notable | buy 2 | J Erik Fyrwald CEO | $2.0M | 25,000 | +581% | - | |
| 57Moderate | sell | Yuvraj Arora President, Nourish | $459k | 5,000 | -61% | - |
Congressional trades
3 trades in IFF disclosed by members of Congress under the STOCK Act. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | IFF International Flavors & Fragrances, Inc. Common Stock | $1,001 to $15k | Nov 18, 2025 | 27 days after the trade |
| Robert P. Bresnahan, Jr. House · R-PA | Sale | IFF International Flavors & Fragrances, Inc. Common Stock | $1,001 to $15k | May 15, 2025 | 16 days after the trade |
| Jefferson Shreve House · R-IN | Sale | IFF International Flavors & Fragrances, Inc. Common Stock | $15k to $50k | Apr 7, 2025 | 31 days after the trade |
Transactions
The last 24 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 4, 2025 | Deborah Borg EVP, Chief Ppl&Culture Officer | AGrant or award Common Stock | +269 | $0.00 | $0 | 23,502 | Mar 6, 2025 |
| Mar 4, 2025 | de Mendonca Ana Paula Teles President, Scent | AGrant or award Common Stock | +35 | $0.00 | $0 | 951 | Mar 6, 2025 |
| Mar 4, 2025 | Angela Strzelecki President, Pharma Solutions | AGrant or award Common Stock | +96 | $0.00 | $0 | 8,635 | Mar 6, 2025 |
| Mar 4, 2025 | Jennifer Amy Johnson EVP, General Counsel | AGrant or award Common Stock | +186 | $0.00 | $0 | 7,357 | Mar 6, 2025 |
| Mar 4, 2025 | Simon Herriott Pres. Health & Bioscience | AGrant or award Common Stock | +237 | $0.00 | $0 | 10,841 | Mar 6, 2025 |
| Mar 4, 2025 | Michael DeVeau CFO | AGrant or award Common Stock | +101 | $0.00 | $0 | 8,253 | Mar 6, 2025 |
| Mar 5, 2025 | Kevin O'Byrne director | POpen-market purchase Common Stockindirect: By Spouse | +6,500 | $80.44 | $523k | 6,500 | Mar 6, 2025 |
| Mar 4, 2025 | Michael DeVeau CFO | FTax withholding Common Stock | -42 | $79.79 | $3,351 | 8,211 | Mar 6, 2025 |
| Mar 4, 2025 | Simon Herriott Pres. Health & Bioscience | FTax withholding Common Stock | -86 | $79.79 | $6,862 | 10,755 | Mar 6, 2025 |
| Mar 4, 2025 | Jennifer Amy Johnson EVP, General Counsel | FTax withholding Common Stock | -77 | $79.79 | $6,144 | 7,280 | Mar 6, 2025 |
| Mar 4, 2025 | Deborah Borg EVP, Chief Ppl&Culture Officer | FTax withholding Common Stock | -123 | $79.79 | $9,814 | 23,379 | Mar 6, 2025 |
| Mar 4, 2025 | Angela Strzelecki President, Pharma Solutions | FTax withholding Common Stock | -34 | $79.79 | $2,713 | 8,601 | Mar 6, 2025 |
| Mar 4, 2025 | de Mendonca Ana Paula Teles President, Scent | FTax withholding Common Stock | -15 | $79.79 | $1,197 | 936 | Mar 6, 2025 |
| Mar 4, 2025 | J Erik Fyrwald CEO | POpen-market purchase Common Stock | +25,000 | $80.24 | $2.0M | 29,300 | Mar 5, 2025 |
| Feb 3, 2025 | Vincent J Intrieri director | AGrant or award Restricted Stock Unitsderivative | +604 | $0.00 | $0 | 604 | Feb 5, 2025 |
| Feb 3, 2025 | Mehmood Khan director | AGrant or award Restricted Stock Unitsderivative | +604 | $0.00 | $0 | 604 | Feb 5, 2025 |
| Feb 3, 2025 | Cynthia T Jamison director | AGrant or award Restricted Stock Unitsderivative | +604 | $0.00 | $0 | 604 | Feb 5, 2025 |
| Jan 15, 2025 | Beril Yildiz CAO, SVP & Controller | AGrant or award Common Stock | +3,976 | $0.00 | $0 | 5,911 | Jan 17, 2025 |
| Jan 15, 2025 | Beril Yildiz CAO, SVP & Controller | FTax withholding Common Stock | -1,340 | $84.17 | $113k | 4,571 | Jan 17, 2025 |
| Jan 2, 2025 | Andres Roberto Muller President, Food Ingredients | AGrant or award Restricted Stock Unitsderivative | +5,476 | $0.00 | $0 | 5,476 | Jan 13, 2025 |
| Dec 2, 2024 | Ralf Finzel EVP, Global Operations Officer | MOption exercise Common Stock | +5,387 | $0.00 | $0 | 9,622 | Dec 3, 2024 |
| Dec 2, 2024 | Ralf Finzel EVP, Global Operations Officer | FTax withholding Common Stock | -1,943 | $91.27 | $177k | 7,679 | Dec 3, 2024 |
| Dec 2, 2024 | Ralf Finzel EVP, Global Operations Officer | MOption exercise Restricted Stock Unitsderivative | -5,387 | $0.00 | $0 | 19,379 | Dec 3, 2024 |
| Nov 11, 2024 | Yuvraj Arora President, Nourish | SOpen-market sale Common Stock | -5,000 | $91.76 | $459k | 3,238 | Nov 12, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Yuvraj AroraPresident, Nourish
- Deborah BorgEVP, Chief Ppl&Culture Officer
- Michael DeVeauCFO
- Ralf FinzelEVP, Global Operations Officer
- J Erik FyrwaldCEO
- Simon HerriottPres. Health & Bioscience
- Vincent J Intrieridirector
- Cynthia T Jamisondirector, other
- Jennifer Amy JohnsonEVP, General Counsel
- Mehmood Khandirector
- Andres Roberto MullerPresident, Food Ingredients
- Kevin O'Byrnedirector
- Angela StrzeleckiPresident, Pharma Solutions
- de Mendonca Ana Paula TelesPresident, Scent
- Beril YildizCAO, SVP & Controller
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.